Amcor stock hits 52-week low at 7.9 USD

Amcor stock recently reached a 52-week low, hitting a price level of 7.9 USD. According to InvestingPro data, the company maintains a robust 6.4% dividend yield and has raised its dividend for six consecutive years. This milestone reflects a significant downturn for the company, as the stock has experienced a substantial 1-year change of -27.93%. Despite the decline, Amcor maintains fair financial health with an EBITDA of $2.04 billion and analysts have set price targets ranging from $9 to $12. The decline highlights the challenges faced by Amcor in the current market environment, as investors continue to navigate economic uncertainties and sector-specific pressures. The 52-week low marks a notable point of concern for stakeholders, prompting analysts and investors alike to closely monitor the company’s strategic responses and future performance. For deeper insights into Amcor’s valuation and growth prospects, including 8 additional ProTips and comprehensive analysis, check out the detailed Pro Research Report available on InvestingPro.

In other recent news, Amcor reported its fourth-quarter earnings for 2025, which revealed mixed results. The company posted an earnings per share (EPS) of $0.20, slightly below the forecast of $0.21, and reported revenue of $5.08 billion, missing the expected $5.18 billion. Additionally, RBC Capital initiated coverage on Amcor with a Sector Perform rating, highlighting the company’s efforts to achieve USD650 million in synergies from Berry by fiscal year 2028, although RBC estimates these synergies will reach USD590 million. Meanwhile, JPMorgan has initiated coverage with an Overweight rating, emphasizing Amcor’s cash flow strength and setting a price target of $10.00, reflecting a December 2026 outlook. Jefferies has reiterated its Buy rating on Amcor, citing a 10% free cash flow yield, despite weaker volumes in North America. These recent developments present a varied landscape for Amcor as it navigates its financial and strategic objectives.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.